1. Home
  2. SNGX vs MITQ Comparison

SNGX vs MITQ Comparison

Compare SNGX & MITQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNGX
  • MITQ
  • Stock Information
  • Founded
  • SNGX 1987
  • MITQ N/A
  • Country
  • SNGX United States
  • MITQ United States
  • Employees
  • SNGX N/A
  • MITQ N/A
  • Industry
  • SNGX Biotechnology: Pharmaceutical Preparations
  • MITQ Telecommunications Equipment
  • Sector
  • SNGX Health Care
  • MITQ Telecommunications
  • Exchange
  • SNGX Nasdaq
  • MITQ Nasdaq
  • Market Cap
  • SNGX 7.4M
  • MITQ 8.0M
  • IPO Year
  • SNGX 1987
  • MITQ 2021
  • Fundamental
  • Price
  • SNGX $2.32
  • MITQ $0.74
  • Analyst Decision
  • SNGX
  • MITQ
  • Analyst Count
  • SNGX 0
  • MITQ 0
  • Target Price
  • SNGX N/A
  • MITQ N/A
  • AVG Volume (30 Days)
  • SNGX 620.7K
  • MITQ 4.5M
  • Earning Date
  • SNGX 03-14-2025
  • MITQ 02-18-2025
  • Dividend Yield
  • SNGX N/A
  • MITQ N/A
  • EPS Growth
  • SNGX N/A
  • MITQ N/A
  • EPS
  • SNGX N/A
  • MITQ N/A
  • Revenue
  • SNGX $364,183.00
  • MITQ $18,756,000.00
  • Revenue This Year
  • SNGX N/A
  • MITQ N/A
  • Revenue Next Year
  • SNGX $76.64
  • MITQ N/A
  • P/E Ratio
  • SNGX N/A
  • MITQ N/A
  • Revenue Growth
  • SNGX N/A
  • MITQ N/A
  • 52 Week Low
  • SNGX $0.32
  • MITQ $0.42
  • 52 Week High
  • SNGX $14.83
  • MITQ $1.55
  • Technical
  • Relative Strength Index (RSI)
  • SNGX 36.12
  • MITQ 50.27
  • Support Level
  • SNGX $2.23
  • MITQ $0.68
  • Resistance Level
  • SNGX $2.39
  • MITQ $0.76
  • Average True Range (ATR)
  • SNGX 0.17
  • MITQ 0.07
  • MACD
  • SNGX 0.01
  • MITQ -0.01
  • Stochastic Oscillator
  • SNGX 22.12
  • MITQ 21.39

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About MITQ Moving iMage Technologies Inc.

Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.

Share on Social Networks: